Solana (SOL) trades at $86.46 with weak technicals but strong fundamentals. Q1 saw 25.3B transactions as Foundation positions for tokenized stock trading.
Author: Trader Edge
Read More
SoFi enables XRP deposits for 13.7M users as real-world assets on XRP Ledger surge 875%. BlackRock and major institutions explore Ripple technology.
A documentary releasing April 22, 2026 claims to identify Bitcoin’s mysterious creator Satoshi Nakamoto using blockchain analysis and investigative work.
Volo Protocol on Sui blockchain exploited for $3.5M across WBTC, XAUm, and USDC vaults. Team froze $500K and pledged to reimburse affected users.
Ethereum whales bought 700K ETH as spot ETFs logged $493.7M in inflows over 8 days. Negative funding rates keep ETH capped under $2,400 despite bullish signs.
New York’s AG filed lawsuits against Coinbase and Gemini, alleging their prediction market platforms violate state gambling laws and regulations.
Bitcoin recovered to $78K after dropping to $75K amid U.S.-Iran peace talks and Fed Chair nominee Kevin Warsh’s Senate hearing. Nearly $97M liquidated.
Broadcom (AVGO) vs Marvell (MRVL): Analyzing AI revenue growth, valuations, and analyst targets to determine which infrastructure stock offers better returns.
Seagate (STX) hits record $554.21 with 639% yearly gain. Analysts project strong Q3 results while company sells Lyve Cloud business to Wasabi Technologies.
Palantir (PLTR) drops 18% YTD despite Trump endorsement, strong Q4 earnings, and $197 target. Extreme valuation with 231 P/E raises investor concerns.
Arrowhead Pharmaceuticals (ARWR) gained 3.9% after Morgan Stanley upgraded the stock with a $100 target, citing plozasiran’s multibillion-dollar potential.
QuantumScape (QS) delivers Q1 earnings April 22. Analysts expect $0.18 loss, no revenue. Options price 13% move. Is the stock worth buying now?
Morgan Stanley identifies five top stock picks for 2026: Affirm, UnitedHealth, Meta, CrowdStrike, and Seagate. See why analysts favor these names.
Tesla (TSLA) stock slips ahead of Q1 earnings as Wall Street splits—Jefferies raises target to $350 (Hold) while BofA keeps $460 Buy rating.
3M (MMM) shares rose 1.6% after reporting Q1 adjusted EPS of $2.14, surpassing the $1.98 consensus. Full-year 2026 outlook remains intact.